State Street Corp raised its stake in Arrowhead Pharmaceuticals by 8.8% during the third quarter. State Street Corp now owns 6,354,331 shares of the biotechnology company’s stock worth $ ...

December 23, 2024--Arrowhead Pharmaceuticals ... to receive up to 44,350 restricted stock units. The grants are outside the Company’s stockholder-approved equity incentive plans and PASADENA ...

Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on X4 Pharmaceuticals (XFOR – Research Report) today and set a price target of ...

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Alnylam Pharma (ALNY – Research Report) today and set a price target of ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Check the time stamp on this data. Updated AI-Generated Signals for Arrowhead Pharmaceuticals Inc. (ARWR) available here: ...

A federal lawsuit filed this week alleges that the Secretary of Health and Human Services (HHS) has failed to meet the deadline required by federal law to include the COVID-19 vaccine in the National ...

The overdose crisis in one of the most serious public health crises our country has ever faced. Canada's approach to addressing this crisis is focused on providing access to a full continuum of health ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

Arrowhead Pharmaceuticals said Friday that the Food and Drug Administration accepted the company's new drug application for its treatment of familial chylomicronemia syndrome, a severe and rare ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...